Recombinagenic activity of the phorbol ester 12-O-tetradecanoylphorbol-13-acetate in human lymphoblastoid cells - PubMed (original) (raw)
Recombinagenic activity of the phorbol ester 12-O-tetradecanoylphorbol-13-acetate in human lymphoblastoid cells
M Honma et al. Carcinogenesis. 1995 Aug.
Abstract
The potent mouse skin tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) was examined for its mutagenic and recombinagenic activity at the heterozygous thymidine kinase (tk +/-) locus and the hemizygous hypoxanthine phosphoribosyltransferase (hprt +/0) locus in the TK6 human lymphoblastoid cell line. TPA at concentrations of 0.01-1.0 micrograms/ml induced a low frequency of tk mutants showing the slow growth phenotype in a dose-dependent manner, but few normal growth tk mutants or hprt mutants. Concentrations of 1.0-10 micrograms/ml TPA induced all three types of mutants. The molecular structure of tk mutants arising spontaneously or induced by 1.0 and 10 micrograms/ml TPA was investigated by Southern hybridization with a human tk cDNA probe: 86% of all mutants arising after incubation with 10 micrograms/ml TPA lost the entire active tk allele, resulting in loss of heterozygosity (LOH), while 71% of spontaneously arising mutants showed LOH. Densitometric analysis indicated that the majority of LOH mutants induced by TPA were homozygous at the tk locus (retained two copies of the mutant allele), consistent with the occurrence of interchromosomal homologous recombination. These results support the hypothesis that tumor promoters such as TPA may increase the rate of chromosomal mitotic recombination and hence facilitate the segregation of recessive mutations. TPA may thus induce a type of genetic instability during the process of tumor promotion that involves enhanced recombinagenic activity.
Similar articles
- Cytotoxic and mutagenic responses to X-rays and chemical mutagens in normal and p53-mutated human lymphoblastoid cells.
Honma M, Hayashi M, Sofuni T. Honma M, et al. Mutat Res. 1997 Mar 4;374(1):89-98. doi: 10.1016/s0027-5107(96)00223-0. Mutat Res. 1997. PMID: 9067419 - Liver carcinogen aflatoxin B1 as an inducer of mitotic recombination in a human cell line.
Stettler PM, Sengstag C. Stettler PM, et al. Mol Carcinog. 2001 Jul;31(3):125-38. doi: 10.1002/mc.1047. Mol Carcinog. 2001. PMID: 11479921 - [Analysis of loss of heterozygosity induced by vinblastine at tk locus in human lymphoblastoid cell line TK6].
Wang YN, Shuai PQ, Guo YJ, Zhang LS. Wang YN, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2006 Jul;37(4):558-61. Sichuan Da Xue Xue Bao Yi Xue Ban. 2006. PMID: 16909601 Chinese. - Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells.
Honma M. Honma M. Environ Mol Mutagen. 2005 Mar-Apr;45(2-3):162-76. doi: 10.1002/em.20113. Environ Mol Mutagen. 2005. PMID: 15688360 Review. - Co-recombinagenic effects.
Fahrig R. Fahrig R. Mutat Res. 1992 Dec 1;284(1):185-93. doi: 10.1016/0027-5107(92)90032-w. Mutat Res. 1992. PMID: 1279390 Review. No abstract available.
Cited by
- Mutator phenotypes conferred by MLH1 overexpression and by heterozygosity for mlh1 mutations.
Shcherbakova PV, Kunkel TA. Shcherbakova PV, et al. Mol Cell Biol. 1999 Apr;19(4):3177-83. doi: 10.1128/MCB.19.4.3177. Mol Cell Biol. 1999. PMID: 10082584 Free PMC article. - Illegitimate recombination leading to allelic loss and unbalanced translocation in p53-mutated human lymphoblastoid cells.
Honma M, Zhang LS, Hayashi M, Takeshita K, Nakagawa Y, Tanaka N, Sofuni T. Honma M, et al. Mol Cell Biol. 1997 Aug;17(8):4774-81. doi: 10.1128/MCB.17.8.4774. Mol Cell Biol. 1997. PMID: 9234733 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous